These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 27062705)
1. Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers. Li Z; Shu J; Zhang P; Sun W; Yang B; Zhang H Cancer Biomark; 2016; 16(3):477-87. PubMed ID: 27062705 [TBL] [Abstract][Full Text] [Related]
2. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
3. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557 [TBL] [Abstract][Full Text] [Related]
4. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics. Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139 [TBL] [Abstract][Full Text] [Related]
5. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review. Oakley-Girvan I; Davis SW Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925 [TBL] [Abstract][Full Text] [Related]
6. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642 [TBL] [Abstract][Full Text] [Related]
7. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study. Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569 [TBL] [Abstract][Full Text] [Related]
8. High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds. Schumer EM; Trivedi JR; van Berkel V; Black MC; Li M; Fu XA; Bousamra M J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1517-22; discussion 1522-4. PubMed ID: 26412316 [TBL] [Abstract][Full Text] [Related]
9. Vacuum ultraviolet absorption spectroscopy in combination with comprehensive two-dimensional gas chromatography for the monitoring of volatile organic compounds in breath gas: A feasibility study. Gruber B; Groeger T; Harrison D; Zimmermann R J Chromatogr A; 2016 Sep; 1464():141-6. PubMed ID: 27545394 [TBL] [Abstract][Full Text] [Related]
10. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121 [TBL] [Abstract][Full Text] [Related]
11. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis. Zhou J; Huang ZA; Kumar U; Chen DDY Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702 [TBL] [Abstract][Full Text] [Related]
12. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer. Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the relationship between cell viability and volatile organic compound production following DMSO treatment of cultured human cells. Li Z; Shu J; Yang B; Xu C; Zou Y; Sun W Pharmazie; 2016 Dec; 71(12):727-732. PubMed ID: 29442003 [TBL] [Abstract][Full Text] [Related]
14. Breath carbonyl compounds as biomarkers of lung cancer. Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567 [TBL] [Abstract][Full Text] [Related]
15. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up. Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677 [TBL] [Abstract][Full Text] [Related]
16. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath. Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018 [TBL] [Abstract][Full Text] [Related]
17. Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry. Biagini D; Lomonaco T; Ghimenti S; Bellagambi FG; Onor M; Scali MC; Barletta V; Marzilli M; Salvo P; Trivella MG; Fuoco R; Di Francesco F J Breath Res; 2017 Nov; 11(4):047110. PubMed ID: 29052557 [TBL] [Abstract][Full Text] [Related]
18. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis. Dallinga JW; Smolinska A; van Schooten FJ Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934 [TBL] [Abstract][Full Text] [Related]
19. Exhaled breath biopsy: a new cancer detection paradigm. Abderrahman B Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676 [No Abstract] [Full Text] [Related]